The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing treatment preferences among patients with advanced/metastatic renal cell carcinoma in the United States: A discrete choice experiment.
 
Moshe Chaim Ornstein
Consulting or Advisory Role - AVEO; Bristol Myers Squibb Foundation; Eisai; Exelixis; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Aravive (Inst); Astellas Medivation (Inst); AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Surface Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Exelixis; Merck; Pfizer
 
Lisa Rosenblatt
Employment - Bristol Myers Squibb
Stock and Other Ownership Interests - Bristol Myers Squibb
Travel, Accommodations, Expenses - Bristol Myers Squibb
 
Flavia Ejzykowicz
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb; Merck
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Sarah Guttenplan
Employment - Bristol-Myers Squibb/Medarex
 
Viviana Del Tejo
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Xin Yin
Employment - Bristol-Myers Squibb; Merck
Research Funding - Bristol-Myers Squibb
 
Kathleen M. Beusterien
Employment - CernerEnviza
 
deMauri S Mackie
No Relationships to Disclose
 
Oliver Will
Consulting or Advisory Role - Cerner Enviza
Other Relationship - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Pfizer (Inst)
 
Grace Skiles
Research Funding - Biogen (Inst); Bristol Myers Squibb (Inst); Janssen (Inst); Otsuka (Inst); Sanofi (Inst); Teva (Inst)
 
Marc DeCongelio
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene
 
Steven S. Senglaub
Stock and Other Ownership Interests - Aditxt; Citius Pharmaceuticals; Electrocore; Fulcrum Therapeutics; NanoVibronix; Ocugen; OpGen; Tilray; Virpax Pharmaceuticals; Zomedica
Research Funding - Bristol-Myers Squibb (Inst)